Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


How to interpret blood glucose monitoring charts and adjust insulin doses

By Elizabeth Hackett

Interpreting blood glucose results and being able to adjust insulin doses are useful skills for pharmacists to possess.The key to acquiring these skills is in understanding:

  • The insulin regimen and the onset, peak and duration of action for the insulins used
  • The glucose levels to aim for
  • How to titrate insulin doses
  • How all of the above relates to patients’ lifestyles and eating habits

Understanding the regimen

Insulin may be given alone or, for those with type 2 diabetes, with oral antidiabetic drugs (OADs), often metformin. Although this article focuses on adjusting insulin doses, readers should bear in mind that oral doses may also need to be adjusted. The three most commonly used insulin regimens are:

  • Once daily intermediate-acting or long-acting insulin — normally given at bedtime or during the day, usually with an OAD;
  • Twice-daily pre-mixed insulin — one injection before breakfast, one before the evening meal (pre-mixed insulins contain fixed ratios of short- and long-acting insulins);
  • Basal-bolus insulin — three daily injections of rapid- or short-acting insulin with meals and one or two injections of intermediate- or long-acting (basal) insulin.

GSK teaser

The onset, peak and duration profiles of insulin products currentlyavailable in the UK are in the table. These should be used wheninterpreting a blood glucose result, to determine which insulin wasexerting its effect at the time of glucose measurement.

Insulin preparations and their onset, peak and duration of action

PreparationOnset (hr)Peak (hr)Duration (hr)

Soluble insulin

Human Actrapid0.52–58
Humulin S0.51–35–7
Hypurin Bovine Neutral0.5/12–56–8
Apidra (Insulin glulisine)0.2513–4
Humalog (Insulin lispro)0.251–1.52–5
Novorapid (Insulin aspart)0.251–33–5
Hypurin Porcine Neutral0.5/12–56–8
Insuman Rapid0.51–37–9

Biphasic Insulin

Human Mixtard 300.52–1224
Humulin M30.51–8.514–15
NovoMix 300.251–4Up to 24 hrs
Humalog Mix 250.251–222
Humalog Mix 500.251–222
Hypurin Porcine 30/700.54–1224
Insuman Comb 150.52–412–20
Insuman Comb 250.52–412–19
Insuman Comb 500.51–412–16

Isophane Insulin

Hypurin Porcine Isophane26–1224
Insuman Basal13–412–20
Human Insulatard24–1224
Humulin I0.52–818–20
Hypurin Bovine Isophane26–1224

Insulin zinc suspension (mixed)

Hypurin Bovine Lente28–1230

Protamine zinc

Hypurin Bovine Protamine Zinc410–2036

Long-acting analogues

Lantus (Insulin glargine)2–4No peak20–24
Levemir (Insulin detemir)2–46–1416–20

Glucose targets

Glucose levels are usually recorded one to four times a day, depending on the stability of a patient’s condition. If carried out four times daily, glucose levels are usually measured before meals and at bedtime. The following levels are commonly recommended:

  • Before breakfast (fasting level): 5.5–6.0mmol/L (with no nocturnal hypoglycaemia)
  • Before lunch and before evening meal: 4.0–6.0mmol/L
  • Before bed: 6.0–8.0mmol/L

If postprandial (after eating) insulin levels are being monitored, they should be taken two hours after each meal and aim to be less than 8.0mmol/L. Some patients may be set different targets (eg, those elderly patients who are prone to hypoglycaemia).

Altering the dose correctly

When reviewing a blood glucose chart, pharmacists should make a note of any levels that consistently fall outside the recommended target. One-off deviations can be ignored, although hypoglycaemia will usually need to be treated with glucose or glucagon.

Provided other causes can

Blood glucose monitoring chart

be excluded (other causes include infection, which may raise glucose levels, or the consumption of large amounts of alcohol, which may lower levels a few hours later), practitioners should determine which insulin dose is responsible for persistently aberrant glucose levels. This requires the onset, peak and duration of action for each insulin that the patient is prescribed to be considered.

For example, if a patient is prescribed a twice-daily pre-mixed regimen, the morning dose of insulin is responsible for the patient’s pre-lunch and pre-evening meal glucose levels — the short-acting insulin affects the pre-lunch level and the longer-acting insulin affects the pre-evening meal level.

Avoiding common mistakes

  • Do not adjust the insulin dose that follows a deviant glucose level — this will not correct the problem and is likely to cause the next glucose level to be outside the recommended range, creating a cycle of deviant results. The original deviant level will have been caused by the previous insulin dose, so this dose will need to be adjusted the following day.
  • Do not omit the following dose of insulin if a low glucose level is recorded. This is not wise, especially in patients with type 1 diabetes who do not produce their own insulin; therefore will be a risk of diabetic ketoacidosis, which is potentially fatal. Doses may be reduced, but should not be omitted.
  • If there is a known reason for high glucose levels (eg, infection) that requires an insulin dose to be increased temporarily, do not forget to lower the dose again once the problem is resolved.
  • While in hospital, many patients do not consume their normal diet. This should be considered when making adjustments to the insulin regimen for inpatients since, if they go home and eat differently, their glucose levels may alter.
  • If patients have unusual blood glucose readings while in hospital, check their usual insulin injection sites. If a different site is used when in hospital to when at home, the absorption of insulin may alter slightly. Furthermore, if a patient injects insulin into exactly the same place every time, lipohypertrophy may occur, which creates a fatty deposit below the skin. If insulin is injected directly into this deposit, drug absorption can be erratic.

The appropriate insulin dose should then be altered accordingly (see below). Once adjusted, the glucose monitoring chart needs to be reviewed over the following few days to ensure that the adjustment has altered the glucose levels appropriately.

Adjusting insulin doses

Insulin doses should be titrated slowly. A one-off, high glucose level is not likely to be problematic, however hypoglycaemia can be frightening for a patient to experience and may progress to a coma. Care in avoiding hypoglycaemia is the priority.

In most cases the following recommendations for adjusting insulin doses should be appropriate:

  • Short- and rapid-acting insulin — adjust by no more than two units (or 10 per cent of the current dose) daily
  • Intermediate-acting, long-acting and pre-mixed insulin — adjust by no more than two units, or 10 per cent (whichever is greater), every three to four days

If a patient is prescribed more than one type of insulin, adjust one type at a time. If patients are not in hospital while their insulin doses are being stabilised, practitioners may opt to telephone them at home and make recommendations based on glucose readings taken at home. However, many patients can be taught to self-manage, so should be encouraged to do so whenever possible. Some tips on avoiding common mistakes when dealing with diabetic patients are described the Panel.

Individual treatment

The above recommendations are guidelines — each patient’s individual circumstances should be considered. Also, local policies and guidelines may differ slightly from these recommendations, so it is important to check these before adjusting insulin doses.

Elizabeth Hackett is principal pharmacist for diabetes at University Hospitals of Leicester NHS Trust

Reading this article counts towards your CPD

You can use the following forms to record your learning and action points from this article from Pharmaceutical Journal Publications.

Your CPD module results are stored against your account here at The Pharmaceutical Journal. You must be registered and logged into the site to do this. To review your module results, go to the ‘My Account’ tab and then ‘My CPD’.

Any training, learning or development activities that you undertake for CPD can also be recorded as evidence as part of your RPS Faculty practice-based portfolio when preparing for Faculty membership. To start your RPS Faculty journey today, access the portfolio and tools at

If your learning was planned in advance, please click:

If your learning was spontaneous, please click:

Citation: Hospital Pharmacist URI: 10031318

Readers' comments (2)

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Blood glucose monitoring chart

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.